Dipyridamole-induced C-type natriuretic peptide mRNA overexpression in a minipig model of pacing-induced left ventricular dysfunction

Peptides

Volumn 64, Issue , 2015, Pages 67-73

  Cabiati, M ^a   Burchielli, S ^b   Matteucci, M ^c   Svezia, B ^a,c   Panchetti, L ^b   Caselli, C ^a   Prescimone, T ^a   Morales, M A ^a   Del Ry, S ^a  

^a CNR   (Italy)

^b Fondazione Toscana G Monasterio   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

C type natriuretic peptide; Dipyridamole; Left ventricular dysfunction; mRNA; RIA

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIPYRIDAMOLE; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; PLACEBO; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENE EXPRESSION; HEART; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE PACING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MINIPIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION; TRANSTHORACIC ECHOCARDIOGRAPHY; ANIMAL; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; ETIOLOGY; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEART PACING; METABOLISM; PIG; UPREGULATION;

ANIMALS; CARDIAC PACING, ARTIFICIAL; DIPYRIDAMOLE; DISEASE MODELS, ANIMAL; HEART; NATRIURETIC PEPTIDE, C-TYPE; PROTECTIVE AGENTS; RNA, MESSENGER; SWINE; SWINE, MINIATURE; UP-REGULATION; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84921876828     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2015.01.003     Document Type: Article

References (44)

1. D. Abraham, R. Hofbauer, R. Schäfer, R. Blumer, P. Paulus, and A. Miksovsky Selective downregulation of VEGF-A(165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy Circ Res 87 2000 644 647
2. A. Ahluwalia, R.J. MacAllister, and A.J. Hobbs Vascular actions of natriuretic peptides Basic Res Cardiol 99 2004 83 89
3. M. Akhtar, K. Ordovas, A. Martin, C.B. Higgins, and A.D. Michaels Effect of chronic sustained-release dipyridamole on myocardial blood flow and left ventricular function in patients with ischemic cardiomyopathy Congest Heart Fail 13 2007 130 135
4. C.L. Baum, and C.J. Arpey Normal cutaneous wound healing: clinical correlation with cellular and molecular events Dermatol Surg 31 2005 674 686
5. C. Brown, X. Pan, and A. Hassid Nitric oxide and C-type atrial natriuretic peptide stimulate primary aortic smooth muscle cell migration via a cGMP-dependent mechanism: relationship to microfilament dissociation and altered cell morphology Circ Res 84 1999 655 667
6. M. Cabiati, S. Raucci, C. Caselli, M.A. Guzzardi, A. D'Amico, and T. Prescimone Tissue-specific selection of stable reference genes for Real-Time PCR normalization in an obese rat model J Mol Endocrinol 48 2012 251 260
7. R. Cao, E. Brakenhielm, R. Pawliuk, D. Wariaro, M.J. Post, and E. Wahlberg Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 Nat Med 9 2003 604 613
8. W. Casscells Migration of smooth muscle and endothelial cells: critical events in restenosis Circulation 86 1992 723 729
9. M.D. Cerqueira, N.J. Weissman, V. Dilsizian, A.K. Jacobs, S. Kaul, and W.K. Laskey Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American heart association Circulation 105 2002 539 542
10. S.D. Chauhan, H. Nilsson, A. Ahluwalia, and A.J. Hobbs Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor Proc Natl Acad Sci U S A 100 2003 1426 1431
11. H. Chen, Y.C. Levine, D.E. Golan, T. Michel, and A.J. Lin Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium J Biol Chem 283 2008 4439 4447
12. D. Contreras, H. Robles, E. Romo, A. Rios, and B. Escalante The role of nitric oxide in the post-ischemic revascularization process Pharmacol Ther 112 2006 553 563
13. J.P. Cooke NO and angiogenesis Atheroscler Suppl 4 2003 53 60
14. S. Del Ry, M. Cabiati, V. Lionetti, C. Colotti, M. Maltinti, and M. Emdin Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus scrofa Peptides 28 2007 1390 1396
15. S. Del Ry, M. Cabiati, V. Lionetti, M. Emdin, F.A. Recchia, and D. Giannessi Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart Peptides 29 2008 2008 2015
16. S. Del Ry, M. Cabiati, V. Lionetti, A. Simioniuc, C. Caselli, and T. Prescimone Asymmetrical myocardial expression of natriuretic peptides in pacing-induced heart failure Peptides 30 2009 1710 1713
17. S. Del Ry, M. Cabiati, A. Martino, C. Cavallini, C. Caselli, and G.D. Aquaro High concentration of C-type natriuretic peptide promotes VEGF-dependent vasculogenesis in the remodeled region of infarcted swine heart with preserved left ventricular ejection fraction Int J Cardiol 168 2013 2426 2434
18. S. Del Ry, M.A. Morales, M.C. Scali, A. Tafi, C. Giustarini, and F. Posteraro Effect of concomitant oral chronic dipyridamole therapy on inflammatory cytokines in heart failure patients Clin Lab 59 2013 843 849
19. S. Del Ry C-type natriuretic peptide: a new cardiac mediator Peptides 40 2013 93 98
20. R.M. Fryer, J.A. Auchampach, and G.J. Gross Therapeutic receptor targets of ischemic pre-conditioning Cardiovasc Res 55 2002 520 525
21. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, and K. Walsh Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
22. H. Funakoshi, L.C. Zacharia, Z. Tang, J. Zhang, L.L. Lee, and J.C. Good A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction Circulation 115 2007 2307 2315
23. H.P. Gerber, A. McMurtrey, J. Kowalski, M. Yan, B.A. Keyt, and V. Dixit Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation J Biol Chem 273 1998 30336 30343
24. L.J. Ignarro, R.E. Byrns, G.M. Buga, and K.S. Wood Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical Circ Res 61 1987 866 879
25. M. Kitakaze, T. Minamino, K. Node, Y. Koretsune, K. Komamura, and H. Funaya Elevation of plasma adenosine levels may attenuate the severity of chronic heart failure Cardiovasc Drugs Ther 12 1998 307 309
26. D. Kumar, B.G. Branch, C.B. Pattillo, J. Hood, S. Thoma, and S. Simpson Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis Proc Natl Acad Sci U S A 105 2008 7540 7545
27. M. Lekas, P. Lekas, D.A. Latter, M.B. Kutryk, and D.J. Stewart Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation Curr Opin Cardiol 21 2006 376 384
28. D.M. Lloyd-Jones, and K.D. Bloch The vascular biology of nitric oxide and its role in atherogenesis Annu Rev Med 47 1996 365 375
29. A. Martino, M. Cabiati, M. Campan, T. Prescimone, D. Minocci, and C. Caselli Selection of reference genes for normalization of Real-Time PCR data in minipig heart failure model and evaluation of TNF-α mRNA expression J Biotechnol 153 2011 92 99
30. T. Nishikimi, N. Maeda, and H. Matsuoka The role of natriuretic peptides in cardio-protection Cardiovasc Res 69 2006 318 328
31. T. Oka, H. Akazawa, A.T. Naito, and I. Komuro Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure Circ Res 114 2014 565 571
32. G.F. Pedulli, M. Lucarini, E. Marchesi, F. Paolucci, S. Roffia, and D. Fiorentini Medium effects on the antioxidant activity of dipyridamole Free Radic Biol Med 26 1999 295 302
33. S. Roura, F. Planas, C. Prat-Vidal, R. Leta, C. Soler-Botija, and F. Carreras Idiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation Eur J Heart Fail 9 2007 995 1002
34. R.L. Sacco, H.C. Diener, S. Yusuf, D. Cotton, S. Ounpuu, and W.A. Lawton Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke N Engl J Med 359 2008 1238 1251
35. S. Sanada, H. Asanuma, Y. Koretsune, K. Watanabe, S. Nanto, and N. Awata Long-term oral administration of dipyridamole improves both cardiac and physical status in patients with mild to moderate chronic heart failure: a prospective open-randomized study Hypertens Res 30 2007 913 919
36. R. Schäfer, D. Abraham, P. Paulus, R. Blumer, M. Grimm, and J. Wojta Impaired VE-cadherin/beta-catenin expression mediates endothelial cell degeneration in dilated cardiomyopathy Circulation 108 2003 1585 1591
37. L. Schwartz, M.G. Bourassa, J. Lesperance, H.E. Aldridge, F. Kazim, and V.A. Salvatori Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty N Engl J Med 318 1998 1714 1719
38. M.M. Soliman, and M.M. Arafah Treatment with dipyridamole improves cardiac function and prevent injury in a rat model of hemorrhage Eur J Pharmacol 678 2012 26 31
39. J.M. Sullivan, D.E. Harken, and R. Gorlin Pharmacologic control of thromboembolic complications of cardiac-valve replacement N Engl J Med 284 1971 1391 1394
40. D. Tirziu, and M. Simons Angiogenesis in the human heart: gene and cell therapy Angiogenesis 8 2005 241 251
41. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, and A. De Paepe Accurate normalization of Real-Time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 RESEARCH0034
42. P.K. Venkatesh, C.B. Pattillo, B. Branch, J. Hood, S. Thoma, and S. Illum Dipyridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway Cardiovasc Res 85 2010 661 670
43. K. Yamahara, H. Itoh, T.H. Chun, Y. Ogawa, J. Yamashita, and N. Sawada Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration Proc Natl Acad Sci U S A 100 2003 3404 3409
44. J. Yu, E.D. deMuinck, Z. Zhuang, M. Drinane, K. Kauser, and G.M. Rubanyi Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve Proc Natl Acad Sci U S A 102 2005 10999 11004